February 12: The Week in Cancer News
An FDA committee votes to recommend holding off on approval of an immunotherapy for early-stage triple-negative breast cancer, and more news of the week from Cancer Today.
Home > Patients, Caregivers, and Advocates > Research > February 12: The Week in Cancer News
An FDA committee votes to recommend holding off on approval of an immunotherapy for early-stage triple-negative breast cancer, and more news of the week from Cancer Today.
Your donation to the American Association for Cancer Research helps our more than 58,000 members worldwide drive progress against cancer.
Donate Now